Most Read News

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Download App
image

Aban Offshore hit an upper circuit limit of 20% at Rs 57.15 after the company said it has entered into a settlement agreement with Central Bank of India, one of its financial creditors.

image

RBL Bank Ltd is quoting at Rs 129.2, up 6.12% on the day as on 12:49 IST on the NSE. The stock is down 20.52% in last one year as compared to a 6.47% spurt in NIFTY and a 10.7% spurt in the Nifty PSU Bank index.

image

Indian Bank is quoting at Rs 190, up 6.44% on the day as on 12:49 IST on the NSE. The stock is up 54.66% in last one year as compared to a 6.47% jump in NIFTY and a 31.48% jump in the Nifty Pharma index.

image

Union Bank of India is quoting at Rs 42.2, up 4.33% on the day as on 12:49 IST on the NSE. The stock is up 25.78% in last one year as compared to a 6.47% spurt in NIFTY and a 31.48% spurt in the Nifty Pharma index.

image

Canara Bank is quoting at Rs 241.25, up 3.94% on the day as on 12:49 IST on the NSE. The stock is up 57.83% in last one year as compared to a 6.47% gain in NIFTY and a 31.48% gain in the Nifty Pharma index.

image

Punjab National Bank is quoting at Rs 35.35, up 5.37% on the day as on 12:49 IST on the NSE. The stock is down 1.26% in last one year as compared to a 6.47% gain in NIFTY and a 10.79% gain in the Nifty Bank index.

image

Upon full payment of the settlement amount in accordance with the agreement, the Bank will release the security, claim, charges.

image

According to the news report, NARCL wants to provide 15% of the consideration in cash and the remaining 85% in the form of security receipts.

image

Bank of India is quoting at Rs 51.9, up 4.74% on the day as on 12:49 IST on the NSE. The stock is down 21.06% in last one year as compared to a 6.47% jump in NIFTY and a 31.48% jump in the Nifty Pharma index.

image

Business Wire India Galderma:   Continued strong commercial and financial performance in a resilient market   Galderma delivered continued strong growth across product categories, with net sales up 15% year-on-year on a constant currency basis at 1,914 M USD Particularly strong performance of Injectable Aesthetics and Dermo-cosmetics product categories with growth of 32% and 31% on a constant currency basis, respectively Volume as a primary […]

Image
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.